EUVIMEDEUVIMED entdecken
Crossref

Global and regional burden of vaccine‐associated facial paralysis, 1967–2023: Findings from the WHO international pharmacovigilance database

Yi Deun Jeong, Kyeongmin Lee, Sooji Lee, Jaeyu Park, Hyeon Jin Kim, Jinseok Lee, Jiseung Kang, Louis Jacob, Lee Smith, Masoud Rahmati, Guillermo F López Sánchez, Elena Dragioti und 5 weitere

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29682 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Yi Deun Jeong und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Kyung Hee University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Facial Paralysis, Pharmacovigilance, World Health Organization, Databases, Factual. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The scarce and conflicting data on vaccine‐associated facial paralysis limit our understanding of vaccine safety on a global scale. Therefore, this study aims to evaluate the global burden of vaccine‐associated facial paralysis and to identify the extent of its association with individual vaccines, thereby contributing to the development of a more effective vaccination program. We used data on vaccine‐associated facial paralysis from 1967 to 2023 (total reports, n = 131 255 418 418) from the World Health Organization International Pharmacovigilance Database. Global reporting counts, reported odds ratios (ROR), and information components (ICs) were computed to elucidate the association between the 16 vaccines and the occurrence of vaccine‐associated facial paralysis across 156 countries. We identified 26 197 reports (men, n = 10 507 [40.11%]) of vaccine‐associated facial paralysis from 49 537 reports of all‐cause facial paralysis. Vaccine‐associated facial paralysis has been consistently reported; however, a pronounced increase in reported incidence has emerged after the onset of the coronavirus disease 2019 (COVID‐19) pandemic, which is attributable to the COVID‐19 mRNA vaccine. Most vaccines were associated with facial paralysis, with differing levels of association, except for tuberculosis vaccines. COVID‐19 mRNA vaccines had the highest association with facial paralysis reports (ROR, 28.31 [95% confidence interval, 27.60–29.03]; IC, 3.37 [IC 0.25 , 3.35]), followed by encephalitis, influenza, hepatitis A, papillomavirus, hepatitis B, typhoid, varicella‐zoster, meningococcal, Ad‐5 vectored COVID‐19, measles, mumps and rubella, diphtheria, tetanus toxoids, pertussis, polio, and Hemophilus influenza type b, pneumococcal, rotavirus diarrhea, and inactivated whole‐virus COVID‐19 vaccines. Concerning age‐ and sex‐specific risks, vaccine‐associated facial paralysis was more strongly associated with older age groups and males. The serious adverse outcome and death rate of vaccine‐associated facial paralysis were extremely low (0.07% and 0.00%, respectively). An increase in vaccine‐induced facial paralysis, primarily owing to COVID‐19 mRNA vaccines, was observed with most vaccines, except tuberculosis vaccines. Given the higher association observed in the older and male groups with vaccine‐associated facial paralysis, close monitoring of these demographics when administering vaccines that are significantly associated with adverse reactions is crucial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Facial ParalysisPharmacovigilanceWorld Health OrganizationDatabases, FactualHumansMaleFemaleAdultMiddle AgedAdolescentYoung AdultChildChild, PreschoolAgedIncidenceVaccinesGlobal HealthCOVID-19InfantVaccinationSARS-CoV-2

Stichwörter der Autor:innen

World Health Organizationfacial paralysisglobalvaccinevaccine‐associated facial paralysis

Substanzen

Vaccines

Autor:innen und Institutionen

  • Department of Medicine, Kyung Hee University College of Medicine, Seoul, South Korea.
  • Center for Digital Health, Medical Science Research Institute, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea.
  • Department of Regulatory Science, Kyung Hee University, Seoul, South Korea.
  • Department of Biomedical Engineering, Kyung Hee University, Yongin, South Korea.
  • Division of Sleep Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Dong Keon Yon

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Jeong, Y. D., Lee, K., Lee, S., Park, J., Kim, H. J., Lee, J., Kang, J., Jacob, L., Smith, L., Rahmati, M., López Sánchez, G. F., Dragioti, E., Son, Y., Kim, S., Yeo, S. G., Lee, H., & Yon, D. K. (2024). Global and regional burden of vaccine‐associated facial paralysis, 1967–2023: Findings from the WHO international pharmacovigilance database. Journal of Medical Virology. https://doi.org/10.1002/jmv.29682

Vancouver

Jeong YD, Lee K, Lee S, Park J, Kim HJ, Lee J, et al. Global and regional burden of vaccine‐associated facial paralysis, 1967–2023: Findings from the WHO international pharmacovigilance database. Journal of Medical Virology. 2024. doi:10.1002/jmv.29682

BibTeX
@article{Jeong2024,
  author = {Jeong, Yi Deun and Lee, Kyeongmin and Lee, Sooji and Park, Jaeyu and Kim, Hyeon Jin and Lee, Jinseok and Kang, Jiseung and Jacob, Louis and Smith, Lee and Rahmati, Masoud and López Sánchez, Guillermo F and Dragioti, Elena and Son, Yejun and Kim, Soeun and Yeo, Seung Geun and Lee, Hayeon and Yon, Dong Keon},
  title = {Global and regional burden of vaccine‐associated facial paralysis, 1967–2023: Findings from the WHO international pharmacovigilance database},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29682}
}
Kostenlos starten →